Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
379
-
Total 13F shares, excl. options
-
126M
-
Shares change
-
+20.7M
-
Total reported value, excl. options
-
$8.13B
-
Value change
-
+$1.31B
-
Put/Call ratio
-
1.69
-
Number of buys
-
226
-
Number of sells
-
-144
-
Price
-
$64.27
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q2 2019
469 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q2 2019.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 379 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126M shares
of 159M outstanding shares and own 79.79% of the company stock.
Largest 10 shareholders include FMR LLC (20.9M shares), VANGUARD GROUP INC (12.9M shares), Clearbridge Investments, LLC (9.5M shares), BlackRock Inc. (8.8M shares), BAILLIE GIFFORD & CO (8.44M shares), Bellevue Group AG (7.96M shares), WELLINGTON MANAGEMENT GROUP LLP (7.66M shares), STATE STREET CORP (3.59M shares), WADDELL & REED FINANCIAL INC (3.18M shares), and Invesco Ltd. (2.27M shares).
This table shows the top 379 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.